Stocks
Vor Biopharma Inc.VOR
NASDAQHealthcareBiotechnology$18.33
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing engineered hematopoietic stem cell therapies for blood cancers, with a lead candidate in early trials for acute myeloid leukemia. Investors track it for its novel approach to improving the safety and efficacy of cancer treatments.
52W Range: $6.50-$28.66
Congressional Interest in Vor Biopharma Inc. (VOR)
No congressional trades have been disclosed for Vor Biopharma Inc. (VOR) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading VOR?
No congressional trades found for this stock.